Lv3
390 积分 2021-07-14 加入
Clinical characteristics and survival outcomes of patients with Primary Central Nervous System Lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
14天前
已完结
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
1个月前
已完结
Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis
1个月前
已完结
Mitochondrial regulation of ferroptosis
1个月前
已完结
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
1个月前
已完结
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost–benefit analysis
1个月前
已完结
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
1个月前
已完结
Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (I.E.L.S.G. #20 Trial): Tolerability, activity, and survival analyses
1个月前
已关闭
Treatment of new-onset primary central nervous system lymphoma in elderly patients using RMPV chemotherapy: a single-institution experience
1个月前
已完结
First line treatments in primary central nervous system lymphomas in young patients
1个月前
已完结
皖公网安备34019202002308
